Breed impacts diagnosis, prognosis of MMVD in dogsFebruary 23, 2022The clinical signs of myxomatous mitral valve disease in dogs vary depending on breed, which could impact a patient’s diagnosis and prognosis.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Tufts researchers find first genomic biomarkers in extracellular vesiclesJuly 27, 2017Important biomarkers have been found in extracellular vesicles in dogs with myxomatous mitral valve disease (MMVD) and congestive heart failure, according to researchers at Cummings School of Veterinary Medicine at Tufts University in Grafton, Mass.
